Matches in Nanopublications for { ?s ?p "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP709440.RARDNdAdnNTDkhizc1_7ADWqWZr2zZH2huAIdUKSWb4gk130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709440.RARDNdAdnNTDkhizc1_7ADWqWZr2zZH2huAIdUKSWb4gk130_provenance.
- assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_provenance.
- NP472568.RACH87ZieHCABkAh5xgpcTdKl3E_dlPm1d6JdzCFxAR24130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472568.RACH87ZieHCABkAh5xgpcTdKl3E_dlPm1d6JdzCFxAR24130_provenance.
- NP342507.RAsa8j16vMiQFBtIVhhxO4im7mct8JBN8Rpaa18nqcZ7k130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342507.RAsa8j16vMiQFBtIVhhxO4im7mct8JBN8Rpaa18nqcZ7k130_provenance.
- NP472606.RA_WyMuDVstF30jgoOwn-kW2FEEmKAuHohDpyrDHbi6jg130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472606.RA_WyMuDVstF30jgoOwn-kW2FEEmKAuHohDpyrDHbi6jg130_provenance.
- NP342505.RAPmH0W_s-YUNjqWauG-A36ILzU0sTnwd4TAP35P9NG5k130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342505.RAPmH0W_s-YUNjqWauG-A36ILzU0sTnwd4TAP35P9NG5k130_provenance.
- NP709478.RA6FC3TlSHFQMv30eR6Icz2PjshQWS6w5YdxO30wQAqIk130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709478.RA6FC3TlSHFQMv30eR6Icz2PjshQWS6w5YdxO30wQAqIk130_provenance.
- NP342504.RA6YOXITDD0XuFwMBA5ixIPOS926t5KKpyhj0R43Z0_GY130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342504.RA6YOXITDD0XuFwMBA5ixIPOS926t5KKpyhj0R43Z0_GY130_provenance.